Myelodysplastic Syndrome Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Personalized Prediction Model for Myelodysplastic Syndromes - Certain mutations predict non-malignant conditions
Sudipto Mukherjee, MD from Cleveland Clinics discusses personalized prediction model for Myelodysplastic Syndromes and certain mutations predict non-malignant conditions at the 2017 American Society o... Author: ASHReport Added: 01/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2018 Category: Cancer & Oncology Source Type: podcasts

Predicting Survival Myelodysplastic Syndrome - Using the Random Survival Forest Algorithm
Aziz Nazha, MD from the Cleveland Clinic discusses predicting Survival Myelodysplastic Syndrome and using the Random Survival Forest Algorithm at the 2017 American Society of Hematology. Author: ASHReport Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Algorithm Picks Relevant Variables Variables help predict survivability with myelodysplastic syndromes
Aziz Nazha, MD from the Cleveland Clinic discusses algorithm picks relevant variables and variables help predict survivability with myelodysplastic syndromes at the 2017 American Society of Hematology... Author: ASHReport Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Promising results in MDS for ASTX727, an oral decitabine and cytidine deaminase inhibitor agent
Decitabine, a DNA methyltransferase (DNMT) inhibitor, which is given to patients with myelodysplastic syndromes (MDS), is classically administered intravenously. Now, ASTX727, an oral combination of d... Author: VJHemOnc Added: 01/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Pracinostat for AML update: follow-up analysis and Phase III trial
Pracinostat is a histone deacetylase (HDAC) inhibitor that has demonstrated very promising efficacy in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Here, Guillermo Garcia-Manero, ... Author: VJHemOnc Added: 01/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2018 Category: Cancer & Oncology Source Type: podcasts

MDS and MPNs update from ASH 2017
In this exciting interview, Claire Harrison, MD, DM, FRCP, FRCPath, of Guy's and St Thomas' NHS Foundation Trust, London, UK, discusses the data on myelodysplastic syndromes (MDS) and myeloproliferati... Author: VJHemOnc Added: 12/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Oral azacitidine maintenance therapy for post-transplant AML
Relapse remains the main obstacle for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) after allogeneic stem cell transplantation and novel therapeutic strategies are urg... Author: VJHemOnc Added: 12/18/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2017 Category: Cancer & Oncology Source Type: podcasts

New salvage treatment for AML/MDS after allogeneic transplant: the VIOLA trial
The outcome for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) after allogeneic stem cell transplantation remains poor. In this interview, Charles Craddock, CBE, FRCP (U... Author: VJHemOnc Added: 12/18/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2017 Category: Cancer & Oncology Source Type: podcasts

The future of AML and MDS diagnosis and treatment
There is currently a conundrum regarding the differentiation of acute myeloid leukemia and myelodysplastic syndromes. In this interview, Stphane de Botton, MD, PhD of the Gustave Roussy Institute, Vi... Author: VJHemOnc Added: 12/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Developing an understanding of disease progression in MDS and AML
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) increasingly appear to be influenced by genetic features, with new research attempting to provide a clearer understanding of how geneti... Author: VJHemOnc Added: 11/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Topical challenges in the management of ET
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Ji Schwarz discusses challenges in the management of essential thrombocythemia. ... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Biology and therapy of eosinophilic neoplasms
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Andreas Reiter discusses the biology and therapy of eosinophilic neoplasms. Earn... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Mechanisms of bone marrow fibrosis in Myelofibrosis
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Jean Luc Villeval discusses the mechanisms of bone marrow fibrosis in patients with... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts

New mouse models of MPN
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Radek C. Skoda discusses new mouse models of myeloproliferative neoplasms (MPN). ... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Role of immune system in MDS pathogenesis
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Astrid Olsnes Kittang discusses the role of the immune system in the pathogenesis o... Author: imedex Added: 10/30/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 30, 2017 Category: Cancer & Oncology Source Type: podcasts